120 related articles for article (PubMed ID: 21125165)
1. Takayasu arteritis: anti-TNF therapy in a Brazilian setting.
Nunes G; Neves FS; Melo FM; de Castro GR; Zimmermann AF; Pereira IA
Rev Bras Reumatol; 2010; 50(3):291-8. PubMed ID: 21125165
[TBL] [Abstract][Full Text] [Related]
2. Anti TNF-α in refractory Takayasu's arteritis: cases series and review of the literature.
Comarmond C; Plaisier E; Dahan K; Mirault T; Emmerich J; Amoura Z; Cacoub P; Saadoun D
Autoimmun Rev; 2012 Jul; 11(9):678-84. PubMed ID: 22155781
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor inhibitors in patients with Takayasu arteritis: experience from a referral center with long-term followup.
Schmidt J; Kermani TA; Bacani AK; Crowson CS; Matteson EL; Warrington KJ
Arthritis Care Res (Hoboken); 2012 Jul; 64(7):1079-83. PubMed ID: 22328491
[TBL] [Abstract][Full Text] [Related]
4. Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis.
Hoffman GS; Merkel PA; Brasington RD; Lenschow DJ; Liang P
Arthritis Rheum; 2004 Jul; 50(7):2296-304. PubMed ID: 15248230
[TBL] [Abstract][Full Text] [Related]
5. Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up.
Molloy ES; Langford CA; Clark TM; Gota CE; Hoffman GS
Ann Rheum Dis; 2008 Nov; 67(11):1567-9. PubMed ID: 18677012
[TBL] [Abstract][Full Text] [Related]
6. Refractory Takayasu arteritis successfully treated with infliximab.
Maffei S; Di Renzo M; Santoro S; Puccetti L; Pasqui AL
Eur Rev Med Pharmacol Sci; 2009; 13(1):63-5. PubMed ID: 19364087
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Takayasu's arteritis with tumor necrosis factor antagonists.
Filocamo G; Buoncompagni A; Viola S; Loy A; Malattia C; Ravelli A; Martini A
J Pediatr; 2008 Sep; 153(3):432-4. PubMed ID: 18718263
[TBL] [Abstract][Full Text] [Related]
8. Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients.
Maksimowicz-McKinnon K; Clark TM; Hoffman GS
Arthritis Rheum; 2007 Mar; 56(3):1000-9. PubMed ID: 17328078
[TBL] [Abstract][Full Text] [Related]
9. [Takayasu's arteritis: underestimated cause of hypertension].
Cybulska I; Makowiecka-Cieśla M; Florczak E
Przegl Lek; 2001; 58(6):490-4. PubMed ID: 11816738
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Pediatric Takayasu arteritis with infliximab and cyclophosphamide: experience from an American-Brazilian cohort study.
Stern S; Clemente G; Reiff A; Ramos MP; Marzan KA; Terreri MT
J Clin Rheumatol; 2014 Jun; 20(4):183-8. PubMed ID: 24847743
[TBL] [Abstract][Full Text] [Related]
11. Serial analysis of clinical and imaging indices reveals prolonged efficacy of TNF-α and IL-6 receptor targeted therapies in refractory Takayasu arteritis.
Youngstein T; Peters JE; Hamdulay SS; Mewar D; Price-Forbes A; Lloyd M; Jeffery R; Kinderlerer AR; Mason JC
Clin Exp Rheumatol; 2014; 32(3 Suppl 82):S11-8. PubMed ID: 24093733
[TBL] [Abstract][Full Text] [Related]
12. Combined immunosuppressive therapy including a TNF-alpha blocker induces remission in a difficult to treat patient with Takayasu arteriitis and coronary involvement.
Mahlmann A; Pfluecke C; Ouda A; Simonis G; Weiss N; Kappert U
Vasa; 2012 Nov; 41(6):451-7. PubMed ID: 23129041
[TBL] [Abstract][Full Text] [Related]
13. Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases.
Fautrel B; Sibilia J; Mariette X; Combe B;
Ann Rheum Dis; 2005 Feb; 64(2):262-6. PubMed ID: 15184196
[TBL] [Abstract][Full Text] [Related]
14. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Hyrich KL; Watson KD; Silman AJ; Symmons DP;
Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
[TBL] [Abstract][Full Text] [Related]
15. Effects of immunosuppressive and biological agents on refractory Takayasu arteritis patients unresponsive to glucocorticoid treatment.
Ohigashi H; Tamura N; Ebana Y; Harigai M; Maejima Y; Ashikaga T; Isobe M
J Cardiol; 2017 May; 69(5):774-778. PubMed ID: 27567177
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerance of infliximab in refractory Takayasu arteritis: French multicentre study.
Mekinian A; Néel A; Sibilia J; Cohen P; Connault J; Lambert M; Federici L; Berthier S; Fiessinger JN; Godeau B; Marie I; Guillevin L; Hamidou M; Fain O;
Rheumatology (Oxford); 2012 May; 51(5):882-6. PubMed ID: 22223706
[TBL] [Abstract][Full Text] [Related]
17. Refractory Takayasu's arteritis successfully treated with the human, monoclonal anti-tumor necrosis factor antibody adalimumab.
Tatò F; Rieger J; Hoffmann U
Int Angiol; 2005 Sep; 24(3):304-7. PubMed ID: 16158044
[TBL] [Abstract][Full Text] [Related]
18. Two Takayasu arteritis patients successfully treated with infliximab: a potential disease-modifying agent?
Della Rossa A; Tavoni A; Merlini G; Baldini C; Sebastiani M; Lombardi M; Neglia D; Bombardieri S
Rheumatology (Oxford); 2005 Aug; 44(8):1074-5. PubMed ID: 15840604
[No Abstract] [Full Text] [Related]
19. TNF inhibitors appear to inhibit disease progression and improve outcome in Takayasu arteritis; an observational, population-based time trend study.
Gudbrandsson B; Molberg Ø; Palm Ø
Arthritis Res Ther; 2017 May; 19(1):99. PubMed ID: 28521841
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of large vessel vasculitis].
Alvarez-Hernández E
Reumatol Clin; 2011 Dec; 7 Suppl 3():S28-32. PubMed ID: 22152287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]